KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Change in Receivables (2020 - 2025)

Ginkgo Bioworks Holdings filings provide 6 years of Change in Receivables readings, the most recent being $1.8 million for Q4 2025.

  • On a quarterly basis, Change in Receivables rose 232.12% to $1.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.5 million, a 68.83% decrease, with the full-year FY2025 number at $1.5 million, down 68.83% from a year prior.
  • Change in Receivables hit $1.8 million in Q4 2025 for Ginkgo Bioworks Holdings, up from -$757000.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $85.4 million in Q4 2021 to a low of -$59.1 million in Q3 2022.
  • Median Change in Receivables over the past 5 years was -$115500.0 (2023), compared with a mean of $760000.0.
  • Biggest five-year swings in Change in Receivables: plummeted 533.87% in 2023 and later soared 1187.07% in 2024.
  • Ginkgo Bioworks Holdings' Change in Receivables stood at $85.4 million in 2021, then plummeted by 140.39% to -$34.5 million in 2022, then rose by 16.24% to -$28.9 million in 2023, then surged by 95.24% to -$1.4 million in 2024, then soared by 232.12% to $1.8 million in 2025.
  • The last three reported values for Change in Receivables were $1.8 million (Q4 2025), -$757000.0 (Q3 2025), and -$4.3 million (Q2 2025) per Business Quant data.